Cardiovascular Monitoring and Cardiovascular Drug Therapy

  • Dietrich Klauwer
  • Christoph Neuhaeuser


Chapter 3 deals with the monitoring options on a pediatric intensive care unit (ICU). From history-taking through clinical findings to monitored vital signs and laboratory values, the basics are described to provide an understanding of circulatory therapy. Additionally, an introduction is given to the principles of postoperative cardiovascular therapy.

Suggested Reading

  1. 1.
    Brunton L, et al. Goodman and Gilman’s the pharmacological basis of therapeutics. 13th ed. New York: McGraw Hill Education; 2017.Google Scholar
  2. 2.
    Haas NA, Camphausen CK, Kececioglu D. Clinical review: thyroid hormone replacement in children after cardiac surgery – is it worth a try? Crit Care. 2016;10:213.CrossRefGoogle Scholar
  3. 3.
    Hahn RG, et al. Perioperative fluid therapy. New York: Informa Healthcare; 2006.CrossRefGoogle Scholar
  4. 4.
    Hausdorf G. Intensivtherapie angeborener Herzfehler. Darmstadt: Steinkopff; 2000.Google Scholar
  5. 5.
    Hirsch JC, Charpie JR, Ohye RG, Gurney G. Near-infrared spectroscopy: what we know and what we need to know – a systematic review of the congenital heart disease literature. J Thorac Cardiovasc Surg. 2009;137:154–9.CrossRefGoogle Scholar
  6. 6.
    Magliola R, et al. Levosimendan, a new inotropic drug: experience in children with acute heart failure. Arch Argent Pediatr. 2009;107:139–45.PubMedGoogle Scholar
  7. 7.
    Moerman A, et al. Cerebral near-infrared spectroscopy in the care of patients during cardiological procedures: a summary of the clinical evidence. J Clin Monit Comput. 2016;30(6):901–9. Epub 2015 Oct 8.CrossRefGoogle Scholar
  8. 8.
    Munoz R, et al. Handbook of pediatric cardiovascular drugs. Heidelberg: Springer; 2008.CrossRefGoogle Scholar
  9. 9.
    Nichols DG, et al. Critical heart disease in infants and children. Philadelphia: Elsevier; 2006.Google Scholar
  10. 10.
    Pinsky MR, Payen D. Functional hemodynamic monitoring. Heidelberg: Springer; 2004.Google Scholar
  11. 11.
    Schranz D, Voekel NF. “Nihilism” of chronic heart failure therapy in children and why effective therapy is withheld. Eur J Pediatr. 2016;175(4):445–55.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Dietrich Klauwer
    • 1
  • Christoph Neuhaeuser
    • 2
  1. 1.Department of PediatricsSingen Medical Center, Gesundheitsverbund Landkreis Konstanz,Krankenhausbetriebsgesellschaft Hegau-Bodensee-KlinikumSingenGermany
  2. 2.Pediatric Intensive Care Unit, Pediatric Heart Center of Giessen, Children’s Heart Transplantation Center, UKGM GmbHGiessenGermany

Personalised recommendations